FHCNX Fees and Costs — Select Health Care Portfolio
Data updated: 2026-07-24
The net expense ratio is 1.16%: a 0.66% management fee plus a 0.50% 12b-1 fee. This share class carries a maximum front-end sales load of 3.50%. In fiscal 2026 the fund paid $2.0M in broker commissions, 0.0332% of average net assets, and portfolio turnover was 69%.
FHCNX Fees and Expenses
Annual operating expenses and sales charges of FHCNX. Prospectus, as of March 6, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.66% |
| 12b-1 fee | 0.50% |
| Other expenses | 0.00% |
| Gross expense ratio | 1.16% |
| Fee waiver | — |
| Net expense ratio | 1.16% |
| Sales charges | |
|---|---|
| Max front load | 3.50% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
FHCNX Costs Over Time
On $10,000 invested in FHCNX, assuming 5% a year before costs, total costs come to $1,164 over 5 years, cutting the return by 1.99% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $350 | $350 | $350 |
| Fund expenses (net expense ratio 1.16%) | $118 | $366 | $633 |
| Trading costs (broker commissions) | $3 | $10 | $18 |
| Lost growth on money paid in costs | $18 | $74 | $163 |
| Total costs | $488 | $800 | $1,164 |
| Value after costs | $10,012 | $10,776 | $11,599 |
| Impact on return, per year | 4.88% | 2.48% | 1.99% |
FHCNX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending February 28, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0332%
- Total broker commissions: $2.0M
- Bought from dealers (principal trades, not a cost): $125.8M
- Portfolio turnover (prospectus): 69%
- Securities on loan, average value: $157.5M
- Net income from securities lending: $948K (0.015% of average net assets)
FHCNX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| GOLDMAN SACHS GROUP INC (THE) | $231K | 15.70% |
| JEFFERIES FINANCIAL GROUP INC | $215K | 14.56% |
| JPMORGAN CHASE and CO | $190K | 12.88% |
| CITIGROUP INC | $189K | 12.81% |
| MORGAN STANLEY | $186K | 12.61% |
| BANK OF AMERICA CORPORATION | $143K | 9.69% |
| UBS GROUP AG | $95K | 6.41% |
| CONDOR TRADING LLC | $92K | 6.25% |
| THE TORONTO DOMINION BANK | $72K | 4.86% |
| TP ICAP GROUP PLC | $62K | 4.23% |
FHCNX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| MORGAN STANLEY | $35.6M | 28.31% |
| JEFFERIES FINANCIAL GROUP INC | $31.0M | 24.61% |
| BANK OF AMERICA CORPORATION | $14.3M | 11.34% |
| THE TORONTO DOMINION BANK | $10.5M | 8.36% |
| LEERINK PARTNERS LLC | $10.5M | 8.35% |
| JPMORGAN CHASE and CO | $10.4M | 8.28% |
| GOLDMAN SACHS GROUP INC (THE) | $6.8M | 5.39% |
| GUGGENHEIM CAPITAL LLC | $3.9M | 3.09% |
| PIPER SANDLER COS | $2.9M | 2.27% |
Select Health Care Portfolio Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| FHCRX | C000272242 | 0.55% | none |
| FSPHX | Select Health Care Portfolio | 0.62% | — |
| FHCQX | C000272241 | 0.66% | none |
| FHCLX | C000272243 | 0.91% | 5.75% |
| FHCNX | C000272244 | 1.16% | 3.50% |
| FHCPX | C000272245 | 1.66% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.